Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Pico-Tesla initiates Alzheimer’s device trial

Pico-Tesla has initiated a pilot study of its Resonator system in 30 patients with Alzheimer's disease symptoms.

The randomised, double-blind, placebo-controlled pilot study will evaluate if the application of magnetic fields produced by Pico-Tesla’s patented Resonator system will be effective as an adjunctive therapy to oral medications, in reducing Alzheimer’s disease symptoms.

Pico-Tesla’s Magneceutical Therapy uses the Resonator, which generates extremely low-level electromagnetic field (EMF), to reduce the symptoms of Alzheimer’s disease.

The device is currently in clinical trials to evaluate its effectiveness in reducing symptoms of various diseases such as atrial fibrillation, Parkinson’s disease, fibromyalgia and osteoarthritis.